1. Aspirin in the prevention of cancer – Author's reply
Peter M Rothwell 
The Lancet 
Volume 377, Issue 9778, Pages (May 2011)
DOI: /S (11)
Copyright © 2011 Elsevier Ltd Terms and Conditions

2. Figure
Pooled analysis of the effect of randomised allocation to aspirin versus control for a duration of about 5–8 years on the 20-year risk of death due to adenocarcinoma of the oesophagus, during, and after two trials in patients without previous vascular events1,2
The Lancet  , DOI: ( /S (11) )
Copyright © 2011 Elsevier Ltd Terms and Conditions